FN1 and neoplasm: Cancer diagnostic imaging has undergone continuous innovation allowing accurate characterization and monitoring of neoplastic disease [181] and multiple FN1 ligand-agents have been developed for molecular imaging, including nuclear magnetic resonance (MR) and fluorescence imaging.